July 11 (Reuters) – The U.S. Food and Drug Administration on
Monday approved Shire Plc’s lifitegrast eye drops for
treating signs and symptoms of dry eye disease, allowing the
company to bring to…
The post FDA approves Shire’s keenly-watched eye drug appeared first on NASDAQ.